QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
NASDAQ:ALBO

Albireo Pharma - ALBO Earnings Date, Estimates & Call Transcripts

$44.59
0.00 (0.00%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$44.40
$44.74
50-Day Range
$18.01
$44.95
52-Week Range
$16.02
$45.23
Volume
178,167 shs
Average Volume
692,759 shs
Market Capitalization
$923.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.00

Earnings Summary

Upcoming
Earnings Date
Mar. 7Estimated
Actual EPS
(Nov. 8)
-$1.89 Missed By -$0.03
Consensus EPS
(Nov. 8)
-$1.86
Last Year's Q4 EPS
(11/4/2021)
$2.90
Skip Charts & View Estimated and Actual Earnings Data

ALBO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALBO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Albireo Pharma Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($1.95)($1.07)($1.64)
Q2 20233($1.85)($1.65)($1.78)
Q3 20233($1.78)($1.52)($1.68)
Q4 20233($1.86)($1.28)($1.53)
FY 202312($7.44)($5.52)($6.62)

ALBO Earnings Date and Information

Albireo Pharma last announced its earnings results on November 8th, 2022. The biopharmaceutical company reported ($1.89) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.86) by $0.03. The firm had revenue of $9.83 million for the quarter, compared to analysts' expectations of $9.68 million. Albireo Pharma has generated ($6.72) earnings per share over the last year (($6.72) diluted earnings per share). Earnings for Albireo Pharma are expected to grow in the coming year, from ($7.86) to ($6.58) per share. Albireo Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 7th, 2023 based off prior year's report dates.

Albireo Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/7/2023
(Estimated)
        
11/8/2022Q3 2022($1.86)($1.89)($0.03)($1.86)$9.68 million$9.83 million
8/15/2022Q2 2022($1.58)($2.04)($0.46)($2.04)$9.42 million$8.21 million    
5/16/2022Q1 2022($2.02)($2.19)($0.17)($2.19)$7.82 million$6.83 million    
3/1/2022Q4 2021($1.27)($0.57)+$0.70($0.57)$12.30 million$32.52 million    
11/4/20219/30/2021($0.38)$2.90+$3.28($5.42)$22.33 million$3.66 million    
8/4/20216/30/2021($1.92)($1.90)+$0.02($1.90)$2.60 million$2.43 million  
5/5/20213/31/2021($1.72)($2.29)($0.57)($2.29)$2.65 million$1.97 million  
2/24/202112/31/2020($1.90)($1.30)+$0.60($1.30)$2.23 million$2.72 million  
11/10/20209/30/2020($1.51)($1.96)($0.45)($1.96)$1.90 million$2.13 million  
8/6/20206/30/2020($1.65)($1.38)+$0.27($1.38)$1.53 million$1.91 million  
5/7/20203/31/2020($1.39)($2.23)($0.84)($2.23)$1.19 million$1.55 million  
3/2/202012/31/2019($1.58)($0.57)+$1.01($0.57)$1.49 million$6.43 million  
11/6/2019Q3($1.55)($1.73)($0.18)($1.73)$1.38 million$1.39 million  
8/8/2019Q2 2019($1.44)($1.35)+$0.09($1.35)$1.11 million$1.25 million
5/9/20193/31/2019($1.37)($1.39)($0.02)($1.39)$1.20 million$0.57 million
3/7/2019Q4($1.16)($1.34)($0.18)($1.34)$1.94 million$0.57 million
11/13/2018Q3($0.97)($1.17)($0.20)($1.17)$1.55 million$0.24 million
8/7/2018Q2 2018($0.98)($1.22)($0.24)($1.22)$2.00 million$0.73 million
5/17/2018Q1 2018$3.75($0.15)($3.90)($0.15)$55.33 million$11.20 million  
3/15/2018Q4 2017($0.78)($0.55)+$0.23($0.55)  
11/14/2017Q3 2017($0.85)($0.73)+$0.12($0.73)
8/21/20176/30/2017($0.84)($0.86)($0.02)($0.86)
5/10/2017Q2 2017($1.1050)($1.06)+$0.0450($1.06)
8/11/2016Q216($0.05)($0.05)($0.01)
5/9/2016Q2($0.04)($0.09)($0.05)($0.09)
2/16/2016Q1($0.08)($0.05)+$0.03($0.05)
12/17/2015Q315($0.11)($0.05)+$0.06($0.05)  
8/13/2015Q3($0.10)($0.12)($0.02)($0.12)  
5/6/2015Q215($0.23)($0.27)($0.04)($0.25)
2/12/2015Q115($0.18)($0.20)($0.02)($0.28)
12/17/2014Q414($0.27)($0.16)+$0.11($0.22)
8/11/2014Q2 2014($0.26)($0.15)+$0.11($0.15)
5/13/2014Q114($0.26)($0.29)($0.03)($0.29)  
2/6/2014Q4($0.19)($0.20)($0.01)($0.28)
12/18/2013Q4($0.30)($0.04)+$0.26($0.40)  
8/12/2013Q2 2013($11.11)($19.82)($8.71)($19.82)
5/8/2013Q1 2013($12.31)($11.11)+$1.20($11.11)  
2/12/2013Q4 2012($12.91)($12.61)+$0.30($17.41)
12/18/2012Q3 2012($13.81)($12.31)+$1.50($12.01)
8/8/2012Q2 2012($16.22)($13.39)+$2.83($11.10)
5/10/2012Q1 2012($18.02)($13.33)+$4.69($13.33)
2/8/2012Q4 2011($16.82)($13.93)+$2.89($13.93)
12/6/2011Q3 2011($20.42)($15.86)+$4.56($43.73)
8/4/2011Q2 2011($25.23)($17.66)+$7.57($20.91)
5/5/2011Q1 2011($31.23)($24.74)+$6.49($24.74)
2/3/2011Q4 2010($33.63)($24.14)+$9.49($24.14)
12/9/2010Q3 2010($44.44)($37.24)+$7.20($37.24)
8/5/2010Q2 2010($48.05)($43.24)+$4.81($43.24)
5/6/2010Q1 2010($50.45)($52.37)($1.92)($52.37)
2/4/2010Q4 2009($51.65)($56.10)($4.45)($56.10)
12/14/2009Q3 2009($60.06)($52.97)+$7.09($52.97)
8/7/2009Q2 2009($61.26)($56.34)+$4.92($56.34)
5/7/2009Q1 2009($50.45)($58.86)($8.41)($58.86)
2/5/2009Q4 2008($50.45)($50.81)($0.36)($50.81)
12/10/2008Q3 2008($54.05)($63.66)($9.61)($63.66)
8/6/2008Q2 2008($54.05)($51.29)+$2.76($51.29)
5/9/2008Q1 2008($56.46)($52.13)+$4.33($52.13)
2/14/2008Q4 2007($54.05)($65.59)($11.54)($65.59)












Albireo Pharma Earnings - Frequently Asked Questions

When is Albireo Pharma's earnings date?

Albireo Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 7th, 2023 based off last year's report dates. Learn more on ALBO's earnings history.

Did Albireo Pharma beat their earnings estimates last quarter?

In the previous quarter, Albireo Pharma (NASDAQ:ALBO) missed the analysts' consensus estimate of ($1.86) by $0.03 with a reported earnings per share (EPS) of ($1.89). Learn more on analysts' earnings estimate vs. ALBO's actual earnings.

How much revenue does Albireo Pharma generate each year?

Albireo Pharma (NASDAQ:ALBO) has a recorded annual revenue of $40.58 million.

How much profit does Albireo Pharma generate each year?

Albireo Pharma (NASDAQ:ALBO) has a recorded net income of -$34.03 million. ALBO has generated -$6.72 earnings per share over the last four quarters.

What is Albireo Pharma's EPS forecast for next year?

Albireo Pharma's earnings are expected to grow from ($7.86) per share to ($6.58) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ALBO) was last updated on 2/7/2023 by MarketBeat.com Staff